SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-050347
Filing Date
2020-04-23
Accepted
2020-04-23 16:30:24
Documents
3
Period of Report
2020-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2014909-5_8k.htm 8-K 26411
2 EXHIBIT 99.1 tm2014909d5_99-1.htm EX-99.1 26163
3 GRAPHIC tm2014909d5_99-1img01.jpg GRAPHIC 27894
  Complete submission text file 0001104659-20-050347.txt   92542
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 20811363
SIC: 2834 Pharmaceutical Preparations